|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3685 USD | +1.66% |
|
-0.94% | -72.50% |
| 06-08 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
| 05-28 | Soligenix - increases maximum offering under sales agreement by $2.96 million | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 0.41 | 1.42 | 1.12 |
| Spread/Res. | -10.12% | -74.05% | -67.10% |
| Spread/Supp. | +4.45% | +31.56% | +25.77% |
| Support | 0.3528 | 0.2801 | 0.293 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SNGX Stock
- Charts Soligenix, Inc.
Select your edition
All financial news and data tailored to specific country editions
